299 related articles for article (PubMed ID: 31799611)
1. The activating transcription factor 2: an influencer of cancer progression.
Huebner K; Procházka J; Monteiro AC; Mahadevan V; Schneider-Stock R
Mutagenesis; 2019 Dec; 34(5-6):375-389. PubMed ID: 31799611
[TBL] [Abstract][Full Text] [Related]
2. ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities.
Bhoumik A; Ronai Z
Cell Cycle; 2008 Aug; 7(15):2341-5. PubMed ID: 18677098
[TBL] [Abstract][Full Text] [Related]
3. Critical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity.
Hsu CC; Hu CD
J Biol Chem; 2012 Mar; 287(11):8621-32. PubMed ID: 22275354
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2.
Miethe J; Schwartz C; Wottrich K; Wenning D; Klempnauer KH
Oncogene; 2001 Dec; 20(56):8116-24. PubMed ID: 11781825
[TBL] [Abstract][Full Text] [Related]
5. The roles of ATF2 (activating transcription factor 2) in tumorigenesis.
Gozdecka M; Breitwieser W
Biochem Soc Trans; 2012 Feb; 40(1):230-4. PubMed ID: 22260696
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration.
Lv G; Hu Z; Tie Y; Du J; Fu H; Gao X; Zheng X
Oncol Rep; 2014 Sep; 32(3):1021-8. PubMed ID: 24968707
[TBL] [Abstract][Full Text] [Related]
7. Activating transcription factor 2 in mesenchymal tumors.
Endo M; Su L; Nielsen TO
Hum Pathol; 2014 Feb; 45(2):276-84. PubMed ID: 24289970
[TBL] [Abstract][Full Text] [Related]
8. ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.
Watson G; Ronai ZA; Lau E
Pharmacol Res; 2017 May; 119():347-357. PubMed ID: 28212892
[TBL] [Abstract][Full Text] [Related]
9. ATF2 - at the crossroad of nuclear and cytosolic functions.
Lau E; Ronai ZA
J Cell Sci; 2012 Jun; 125(Pt 12):2815-24. PubMed ID: 22685333
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of miR-320a by ATF2, ELK1 and YY1 induces cancer cell apoptosis under ionizing radiation conditions.
Hu Z; Tie Y; Lv G; Zhu J; Fu H; Zheng X
Int J Oncol; 2018 Oct; 53(4):1691-1702. PubMed ID: 30066913
[TBL] [Abstract][Full Text] [Related]
12. A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.
Claps G; Cheli Y; Zhang T; Scortegagna M; Lau E; Kim H; Qi J; Li JL; James B; Dzung A; Levesque MP; Dummer R; Hayward NK; Bosenberg M; Brown KM; Ronai ZA
Cell Rep; 2016 May; 15(9):1884-92. PubMed ID: 27210757
[TBL] [Abstract][Full Text] [Related]
13. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2).
Steinmüller L; Thiel G
Biol Chem; 2003 Apr; 384(4):667-72. PubMed ID: 12751796
[TBL] [Abstract][Full Text] [Related]
14. ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2.
Huebner K; Erlenbach-Wuensch K; Prochazka J; Sheraj I; Hampel C; Mrazkova B; Michalcikova T; Tureckova J; Iatsiuk V; Weissmann A; Ferrazzi F; Kunze P; Nalli E; Sammer E; Gehring A; Cheema MM; Eckstein M; Paap EM; Soederberg A; Fischer C; Paul S; Mahadevan V; Ndreshkjana B; Meier MA; Muehlich S; Geppert CI; Merkel S; Grutzmann R; Roehe A; Banerjee S; Hartmann A; Sedlacek R; Schneider-Stock R
Cell Mol Life Sci; 2022 Jul; 79(8):423. PubMed ID: 35838828
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of miR-204 regulates proliferation, apoptosis and autophagy of cervical cancer cells by targeting ATF2.
Li N; Guo X; Liu L; Wang L; Cheng R
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2529-2535. PubMed ID: 31204513
[No Abstract] [Full Text] [Related]
16. Transient receptor potential melastatin-3 (TRPM3)-induced activation of AP-1 requires Ca2+ ions and the transcription factors c-Jun, ATF2, and ternary complex factor.
Lesch A; Hui X; Lipp P; Thiel G
Mol Pharmacol; 2015 Apr; 87(4):617-28. PubMed ID: 25576487
[TBL] [Abstract][Full Text] [Related]
17. miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.
Zhang S; Gao L; Thakur A; Shi P; Liu F; Feng J; Wang T; Liang Y; Liu JJ; Chen M; Ren H
Tumour Biol; 2016 Aug; 37(8):11177-86. PubMed ID: 26935060
[TBL] [Abstract][Full Text] [Related]
18. Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2.
Walczynski J; Lyons S; Jones N; Breitwieser W
Oncogene; 2014 Feb; 33(8):1027-36. PubMed ID: 23416976
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity.
Bhoumik A; Jones N; Ronai Z
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4222-7. PubMed ID: 15010535
[TBL] [Abstract][Full Text] [Related]
20. Characterization and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labor: identification of a novel ATF2 species with potent transactivation properties.
Bailey J; Phillips RJ; Pollard AJ; Gilmore K; Robson SC; Europe-Finner GN
J Clin Endocrinol Metab; 2002 Apr; 87(4):1717-28. PubMed ID: 11932306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
